Natera (NTRA) Financials

Natera Inc. (NTRA) is a leading and innovative genetic testing company that provides advanced diagnostics to help patients and healthcare professionals make informed decisions. The company's financials reflect its strong market position and steady growth. The income statement shows Natera's revenues and expenses, with gross profit representing the difference between total revenue and the cost of goods sold. Net income from stockholders is the final result after deducting taxes and other expenses. Natera's total revenue has been steadily increasing, indicating the company's success in attracting customers and expanding its testing services. The balance sheet provides a snapshot of Natera's financial health, with total assets reflecting the company's investments and total liabilities representing its obligations. Natera's stockholders' equity reveals the company's net worth, while cash equivalents indicate its readily available cash resources. Net debt reveals Natera's overall debt situation, taking into account its cash reserves. The cash flow statement breaks down the sources and uses of cash, with operating cash flow reflecting Natera's core business activities. Financing cash flow represents the funds generated or used for debt and equity transactions, while investing cash flow shows the company's investment in assets or divestment of assets. Free cash flow is a measure of Natera's cash flow available for use after accounting for capital expenditures. The financials provide valuable insights into Natera's financial performance and position, demonstrating the company's success in the genetic testing market.